My group is interested in developing novel approaches to increase the effectiveness of Cancer Immunotherapy in Solid cancer by several approaches including targeting tumour immunosuppressive networks, increasing the trafficking of T cells to the tumour sites and analyses of the transcriptional profile of tumour infiltrating lymphocytes.